Marc Tessier-Lavigne, Director at Juno Therapeutics, holds 2.11M shares in Denali Therapeutics (Ticker: DNLI), holds 2.43K shares in Regeneron (Ticker: REGN), holds 250.00K shares in Juno Therapeutics (Ticker: JUNO).
What is the percentage of profitable transactions made by Marc Tessier-Lavigne?
The percentage of profitable transactions made by Marc Tessier-Lavigne is 78%.
What is the average return per transaction made by Marc Tessier-Lavigne?
The average return per transaction made by Marc Tessier-Lavigne is 11.30%.
What stocks does Marc Tessier-Lavigne hold?
Marc Tessier-Lavigne holds: JUNO, DNLI, AGIO, REGN, PFE stocks.
What was Marc Tessier-Lavigne’s latest transaction?
Marc Tessier-Lavigne latest transaction was an Uninformative Buy of ―.
What was Marc Tessier-Lavigne's most profitable transaction?
Marc Tessier-Lavigne’s most profitable transaction was an Informative Buy of AGIO stock on April 3, 2014. The return on the trade was 168.30%.
What is Marc Tessier-Lavigne's role in Juno Therapeutics?
Marc Tessier-Lavigne's role in Juno Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.